Roche declares conformity with the new Medical Device Regulation (MDR) for all its Class I medical devices in its diabetes care portfolio. Ensuring compliance with the new MDR strengthens the company’s position as a leader and trusted partner in diabetes care providing products and services of highest quality and safety.

Roche is providing free access to the Pro version of the mySugr app for six months to support people with diabetes in various countries around the world. With the Pro version of the mySugr app, people with diabetes can easily export relevant diabetes data and share them digitally with their doctor.

RocheDiabetes InsulinStart is a service designed for people with type 2 diabetes to ease the transition from oral antidiabetics to a complementary long-acting insulin therapy. By using proven algorithms, the messaging-based service provides support during the critical phase of finding the optimum long-acting insulin dose injected once a day.

mySugr's digital coaching service meets and upholds the National Standards for Diabetes Self-Management and Support (DSMES). This accreditation highlights that mySugr coaches provide the highest quality in education and support to people living with diabetes. Validation supports virtual coaching and education is the future of diabetes care.

The RocheDiabetes Care Platform is one of the key components of Roche’s open ecosystem that connects healthcare professionals seamlessly with people with diabetes. The modular based platform brings together diabetes-relevant data from various sources within a single digital solution, thus providing meaningful, actionable insights for a more personalised approach to diabetes care.